As the biopharmaceutical industry manages operations and expansion of manufacturing capabilities in the U.S. amidst the ongoing coronavirus pandemic, companies are faced with unprecedented challenges. Facility design flexibility and operational resiliency are
critical to mitigate risk.
While biopharmaceutical facilities have always valued crisis proofing operations, new contingency strategies and technologies are becoming the new normal in facility design. In this industry roundtable discussion, we are bringing together a panel of industry
professionals to share what steps they are taking to safeguard manufacturing facilities and address the below topics:
Meet the Panel
Moderator: Allan Schurr
Chief Commercial Officer
Enchanted Rock, LLC
Allan Schurr joined the Enchanted Rock team in 2018 and brings go-to-market expertise from over 30 years of experience in commercial and industrial energy services and innovative utility solutions. Schurr is responsible for corporate and product marketing, direct sales, and channel sales functions.
Schurr holds a Bachelor of Science in mechanical engineering from the University of California, Davis and a Master’s in Business Administration from St. Mary’s College in California. He is also a registered Professional Engineer in the State of California, and he is a co-inventor on seven patents related to distributed energy.
Panelist: Tom Pagliuco
Executive Director, Global Energy Engineering
A 40-year energy industry veteran, Tom manages the Energy Management Program at Abbvie across a global facility portfolio. Prior to this, he developed, implemented, and managed the global energy programs at Allergan, Merck and Schering-Plough – all recognized as ENERGY STAR Partners of the Year. He received the 2008 S-P Environmental Achievement Award, 2014 EnergySMART Energy Innovator Award, and was named a 2017 Energy Manager Today 50. Tom has a Chemical Engineering Degree from the State University of New York at Buffalo.
Panelist: David Teer
Sr. Engineering Manager, Viral-based Therapeutics
David brings more than 26 years of experience in the biotechnology industry in facilities management and engineering roles. His has expertise in Good Manufacturing Practice (cGMP), Good Laboratory Practice (GLP), medical devices, Cell & Gene (CGT), viral manufacturing, contract negotiations, equipment procurement & maintenance, biotechnology, and taxation and lease negotiations. Mr. Teer has served as Sr. Engineering manager for Lonza’s Cell & Gene and Viral Therapeutics Business Unit since August 2010. David is currently active in the Houston Life Sciences Community and is a member of ISPE.
Panelist: Jerry Irwin
Senior Project Director
With more than 30 years of construction management experience, Jerry Irwin manages project profitability for Biotechnology projects at CRB. Encompassing all aspects from project status, staffing and project issues, risk management, and finances that are related to both construction and pre-construction, Jerry capitalizes on challenges facing construction management in the environment today. Jerry holds a Bachelor of Science in Business Management from the University of Missouri.
Not finding a particular topic of interest?
More Pharma Manufacturing webinars are available on demand.